This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

H. Michael Cohen net worth and biography

H. Cohen Biography and Net Worth

Director of Masimo

H Michael Cohen serves as Independent Director of the Company. He has almost 30 years of experience in the healthcare industry. Over the past 19 years, he has held various roles at Deutsche Bank, including Global Head, Healthcare Investment Banking and most recently Vice Chairman, Healthcare Investment Banking. Prior to joining Deutsche Bank, Mr. Cohen worked at SG Cohen, Union Bank of Switzerland, and Booz Allen Hamilton. Mr. Cohen began his career in healthcare at Hambrecht & Quist, where he was a member of the equity research team covering biotechnology, medical device and diagnostic companies. He received his B.A. in Economics from the University of Vermont and his M.B.A. from Columbia University.

What is H. Michael Cohen's net worth?: The estimated net worth of H. Michael Cohen is at least $97,454.64 as of June 4th, 2020. Mr. Cohen owns 717 shares of Masimo stock worth more than $97,455 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Cohen may own. Learn More about H. Michael Cohen's net worth.
How do I contact H. Michael Cohen?: The corporate mailing address for Mr. Cohen and other Masimo executives is 52 DISCOVERY, IRVINE CA, 92618. Masimo can also be reached via phone at (949) 297-7000 and via email at [email protected]. Learn More on H. Michael Cohen's contact information.
Has H. Michael Cohen been buying or selling shares of Masimo?: H. Michael Cohen has not been actively trading shares of Masimo over the course of the past ninety days. Most recently, H Michael Cohen sold 587 shares of the business's stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $225.37, for a transaction totalling $132,292.19. Following the completion of the sale, the director now directly owns 717 shares of the company's stock, valued at $161,590.29. Learn More on H. Michael Cohen's trading history.
Who are Masimo's active insiders?: Masimo's insider roster includes H. Cohen (Director), Jon Coleman (Insider), Joe Kiani (CEO), Tao Levy (EVP), Thomas McClenahan (EVP), Adam Mikkelson (Director), Bilal Muhsin (COO), Craig Reynolds (Director), Anand Sampath (EVP), and Micah Young (CFO). Learn More on Masimo's active insiders.
Are insiders buying or selling shares of Masimo?: During the last twelve months, Masimo insiders bought shares 1 times. They purchased a total of 6,365 shares worth more than $1,000,323.40. The most recent insider tranaction occured on May, 25th when CEO Joe E Kiani bought 6,365 shares worth more than $1,000,323.40. Insiders at Masimo own 9.7% of the company. Learn More about insider trades at Masimo.
Information on this page was last updated on 5/25/2023.

H. Michael Cohen Insider Trading History at Masimo

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/4/2020	Sell	587	$225.37	$132,292.19	717

H. Michael Cohen Buying and Selling Activity at Masimo

Masimo Company Overview

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Today's Range

Now: $135.92

$131.23

$137.76

50 Day Range

MA: $135.72

$126.49

$146.85

2 Week Range

Now: $135.92

$75.22

$195.82

Volume

234,381 shs

Average Volume

394,360 shs

Market Capitalization

$7.19 billion

P/E Ratio

90.01

Dividend Yield

N/A

Beta

0.97